Medical Staff Portal
News, Alerts & Events

Hyoscine butylbromide (Buscopan®) 10 mg tablet shortage

March 12 , 2018

The Issue:

There is a back order of hyoscine butylbromide (Buscopan®) 10 mg tablets. The only Canadian manufacturer of this product is Sanofi. The estimated availability date is early April 2018.

Current stock levels are low and inventory will likely be depleted prior to the resolution of this back order.

Key Messages:

  • Physicians should be aware of the shortage of hyoscine butylbromide tablets.
  • Suggested alternatives* include the following, as clinically appropriate:
    • Dicyclomine tablet
    • Trimebutine tablet
    • Pinaverium tablet
    • Hyoscine butylbromide injection

*Alernatives are provided for clinician information and may not be appropriate for all clinical situations. The information provided does not replace clinician judgement.


Please post this notice in your area and ensure all staff is informed about the change.


Please contact your site pharmacy department with any questions or concerns.

Download PDF